SRX4925954 GSM3444244 SRP166657 SRS3971207 GSM3444244 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA was isolated from the mesangial cells using TRIzol® (Invitrogen) per the manufacturer's instructions. The samples were collected from each group (TGF-β1 and control cells) in triplicate and RNA sequencing (RNA-Seq) and miRNA sequencing (miRNA-Seq) were performed using the Illumina HiSeq™ 2000 sequencing system (BeiJing Genome Institute (BGI) Inc., Shenzhen, China). An analysis of differential RNA (DE-genes) and miRNA (DE-miRNA) expression between samples from TGF-β1-treated and control cells was then conducted. miRNA libraries were prepared for sequencing using standard Illumina protocols. Illumina HiSeq 2000 gds 303444244 GSM3444244 GEO Accession GSM3444244 SRX4925955 GSM3444245 SRP166657 SRS3971208 GSM3444245 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA was isolated from the mesangial cells using TRIzol® (Invitrogen) per the manufacturer's instructions. The samples were collected from each group (TGF-β1 and control cells) in triplicate and RNA sequencing (RNA-Seq) and miRNA sequencing (miRNA-Seq) were performed using the Illumina HiSeq™ 2000 sequencing system (BeiJing Genome Institute (BGI) Inc., Shenzhen, China). An analysis of differential RNA (DE-genes) and miRNA (DE-miRNA) expression between samples from TGF-β1-treated and control cells was then conducted. miRNA libraries were prepared for sequencing using standard Illumina protocols. Illumina HiSeq 2000 gds 303444245 GSM3444245 GEO Accession GSM3444245 SRX4925956 GSM3444246 SRP166657 SRS3971209 GSM3444246 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA was isolated from the mesangial cells using TRIzol® (Invitrogen) per the manufacturer's instructions. The samples were collected from each group (TGF-β1 and control cells) in triplicate and RNA sequencing (RNA-Seq) and miRNA sequencing (miRNA-Seq) were performed using the Illumina HiSeq™ 2000 sequencing system (BeiJing Genome Institute (BGI) Inc., Shenzhen, China). An analysis of differential RNA (DE-genes) and miRNA (DE-miRNA) expression between samples from TGF-β1-treated and control cells was then conducted. miRNA libraries were prepared for sequencing using standard Illumina protocols. Illumina HiSeq 2000 gds 303444246 GSM3444246 GEO Accession GSM3444246 SRX4925957 GSM3444247 SRP166657 SRS3971210 GSM3444247 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA was isolated from the mesangial cells using TRIzol® (Invitrogen) per the manufacturer's instructions. The samples were collected from each group (TGF-β1 and control cells) in triplicate and RNA sequencing (RNA-Seq) and miRNA sequencing (miRNA-Seq) were performed using the Illumina HiSeq™ 2000 sequencing system (BeiJing Genome Institute (BGI) Inc., Shenzhen, China). An analysis of differential RNA (DE-genes) and miRNA (DE-miRNA) expression between samples from TGF-β1-treated and control cells was then conducted. miRNA libraries were prepared for sequencing using standard Illumina protocols. Illumina HiSeq 2000 gds 303444247 GSM3444247 GEO Accession GSM3444247 SRX4925958 GSM3444248 SRP166657 SRS3971211 GSM3444248 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA was isolated from the mesangial cells using TRIzol® (Invitrogen) per the manufacturer's instructions. The samples were collected from each group (TGF-β1 and control cells) in triplicate and RNA sequencing (RNA-Seq) and miRNA sequencing (miRNA-Seq) were performed using the Illumina HiSeq™ 2000 sequencing system (BeiJing Genome Institute (BGI) Inc., Shenzhen, China). An analysis of differential RNA (DE-genes) and miRNA (DE-miRNA) expression between samples from TGF-β1-treated and control cells was then conducted. miRNA libraries were prepared for sequencing using standard Illumina protocols. Illumina HiSeq 2000 gds 303444248 GSM3444248 GEO Accession GSM3444248 SRX4925959 GSM3444249 SRP166657 SRS3971212 GSM3444249 miRNA-Seq TRANSCRIPTOMIC size fractionation Total RNA was isolated from the mesangial cells using TRIzol® (Invitrogen) per the manufacturer's instructions. The samples were collected from each group (TGF-β1 and control cells) in triplicate and RNA sequencing (RNA-Seq) and miRNA sequencing (miRNA-Seq) were performed using the Illumina HiSeq™ 2000 sequencing system (BeiJing Genome Institute (BGI) Inc., Shenzhen, China). An analysis of differential RNA (DE-genes) and miRNA (DE-miRNA) expression between samples from TGF-β1-treated and control cells was then conducted. miRNA libraries were prepared for sequencing using standard Illumina protocols. Illumina HiSeq 2000 gds 303444249 GSM3444249 GEO Accession GSM3444249